Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The combined Antiplatelet and Anticoagulant treatment decreased thrombus formation and
overall mortality. Also the initiation of an efficacious early anticoagulation protocol is
important because of its potential impact on the rate of early thromboembolic complications
after mechanical valve implantation. An important question that remains to be answered is
whether the combination would be cost effective than Warfarin alone, with a reduction in
major bleeding. In addition, the knowledge about its cost-effectiveness has not yet been
established in Egypt. The aim of this trial based economic evaluation is to conduct a
cost-effectiveness analysis for combination of low-dose Aspirin and Warfarin versus Warfarin
alone in prosthetic valve patients from the medical provider perspective specially that a
misconception is still existed between the physicians in Egypt that the cost of complications
is not worthy so our main aim is to test the cost of complications.